These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 3023243)
1. Pharmacodynamics (lung function tests, tremor measurements and cAMP determinations) of a single dose of 0.5 mg terbutaline subcutaneously during sustained-release theophylline medication in patients with asthmatic bronchitis. van der Vet AP; Kreukniet J; Drost RH; Maes RA; Fokkens JK; Hamelink ML Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):569-73. PubMed ID: 3023243 [TBL] [Abstract][Full Text] [Related]
2. Lung function improvement, tremor measurements and c-AMP determinations in a group of ten patients with asthmatic bronchitis after one week sustained release theophylline medication (theophylline plasma level +/- 10 mg/l) compared to one week placebo. Van der Vet AP; Kreukniet J; Drost RH; Maes RA; Fokkens JK; Hamelink ML Int J Clin Pharmacol Ther Toxicol; 1986 Nov; 24(11):638-42. PubMed ID: 3025113 [TBL] [Abstract][Full Text] [Related]
3. Combination therapy of theophylline and terbutaline as sustained-release preparations in patients with asthmatic bronchitis. van der Vet AP; Kreukniet J; van Drost RH; Maes RA; Fokkens JK; Hamelink MJ Int J Clin Pharmacol Ther Toxicol; 1987 Oct; 25(10):558-64. PubMed ID: 2828249 [TBL] [Abstract][Full Text] [Related]
4. Terbutaline sustained-release treatment during one week 5 mg b.i.d. compared to one week placebo: terbutaline plasma levels, c-AMP plasma levels, lung function and tremor measurement. van der Vet AP; Kreukniet J; Drost RH; Maes RA; Fokkens JK; Hamelink ML Int J Clin Pharmacol Ther Toxicol; 1987 Nov; 25(11):609-12. PubMed ID: 2828250 [TBL] [Abstract][Full Text] [Related]
5. The effects of oral and subcutaneous administration of terbutaline in asthmatic patients. van den Berg W; Leferink JG; Maes RA; Fokkens JK; Kreukniet J; Bruynzeel PL Eur J Respir Dis Suppl; 1984; 134():181-93. PubMed ID: 6327346 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (Theograd, 350 mg Theolair Retard, and 300 mg Theolin Retard) in steady state in six normals and six patients with chronic asthmatic bronchitis--Part II: Lung function. van der Vet AP; Kreukniet J; Drost RH; Maes RA Int J Clin Pharmacol Ther Toxicol; 1985 Jul; 23(7):339-44. PubMed ID: 4030161 [TBL] [Abstract][Full Text] [Related]
7. A comparison of a theophylline-ephedrine combination with terbutaline. Bush RK; Smith AM; Welling PG; Alcala JC; Lee TP Ann Allergy; 1978 Jul; 41(1):13-7. PubMed ID: 208429 [TBL] [Abstract][Full Text] [Related]
8. Separate and combined use of terbutaline and theophylline in asthmatics. Effects related to plasma levels. Billing B; Dahlqvist R; Garle M; Hörnblad Y; Ripe E Eur J Respir Dis; 1982 Sep; 63(5):399-409. PubMed ID: 7140872 [TBL] [Abstract][Full Text] [Related]
9. Effectiveness of terbutaline and theophylline alone and in combination in exercise-induced bronchospasm. Shapiro GG; McPhillips JJ; Smith K; Furukawa CT; Pierson WE; Bierman CW Pediatrics; 1981 Apr; 67(4):508-13. PubMed ID: 7019839 [TBL] [Abstract][Full Text] [Related]
10. Long-term oral therapy of asthma with terbutaline and theophylline, alone and combined. Laursen LC; Taudorf E; Gnosspelius Y; Gymose E; Weeke B Eur J Respir Dis; 1985 Feb; 66(2):82-90. PubMed ID: 2578971 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (350 mg Theograd, 350 mg Theolair Retard and 300 mg Theodur) in steady state in healthy volunteers and asthmatics--Part I: Theophylline plasma levels. van der Vet AP; Drost RH; Kreukniet J; Maes RA Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):423-9. PubMed ID: 6490224 [TBL] [Abstract][Full Text] [Related]
12. Tremor measurement in asthma. II. Changes after terbutaline administration suggesting beta-adrenergic blockade. van den Berg W; Fokkens J; Leferink JG; Kreukniet J; Maes RA; Bruynzeel PL Eur J Respir Dis; 1982 Sep; 63(5):392-8. PubMed ID: 6291971 [TBL] [Abstract][Full Text] [Related]
13. [The effect of protheo on pulmonary function and the change of its plasma concentration in patients with chronic asthmatic bronchitis]. Li S; Chen Y; Tan P Zhonghua Jie He He Hu Xi Za Zhi; 1997 Oct; 20(5):299-300. PubMed ID: 10374457 [TBL] [Abstract][Full Text] [Related]
14. Slow-release terbutaline and theophylline for the long-term therapy of children with asthma: a Latin square and factorial study of drug effects and interactions. Chow OK; Fung KP Pediatrics; 1989 Jul; 84(1):119-25. PubMed ID: 2662130 [TBL] [Abstract][Full Text] [Related]
15. Bronchodilator effects of low doses of oral theophylline and terbutaline in asthmatic subjects. Deutsch RI; Tashkin DP; Simmons M; Calvarese B; Wanger J; Lee YE Ann Allergy; 1980 Sep; 45(3):137-43. PubMed ID: 7416558 [TBL] [Abstract][Full Text] [Related]
16. Sustained-release terbutaline vs sustained-release theophylline in young patients with asthma. Roberts JR; Desai HI; Gillespie CA; Simons FE Am J Dis Child; 1986 Jul; 140(7):650-4. PubMed ID: 3717101 [TBL] [Abstract][Full Text] [Related]
17. Simultaneous treatment with terbutaline and theophylline. Billing B; Dahlqvist R; Garle M; Hörnblad Y; Ripe E Eur J Respir Dis Suppl; 1984; 134():211-8. PubMed ID: 6586482 [TBL] [Abstract][Full Text] [Related]